Vitiligo is a common acquired localized or recurrent skin pigment loss disorder. This is caused by the loss of melanocyte function in the skin, but the mechanism is not clear. All parts of the body can occur, common in the back of the finger, wrist, forearm, face, neck and genitals around.
This report contains market size and forecasts of Vitiligo Treatment in Global, including the following market information:
Global Vitiligo Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Vitiligo Treatment market was valued at 1608.8 million in 2021 and is projected to reach US$ 2003.8 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vitiligo Treatment include Incyte, Astellas Pharma, Bausch Health, Baxter, Pfizer, STRATA Skin Sciences, Dr. Reddy's Laboratories, Bristol-Myers Squibb and Celgene and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vitiligo Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vitiligo Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Vitiligo Treatment Market Segment Percentages, by Type, 2021 (%)
Topical Treatment
Light Therapy
Surgical Procedures
Others
Global Vitiligo Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Vitiligo Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Aesthetic Clinics
Others
Global Vitiligo Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Vitiligo Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vitiligo Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Vitiligo Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Incyte
Astellas Pharma
Bausch Health
Baxter
Pfizer
STRATA Skin Sciences
Dr. Reddy's Laboratories
Bristol-Myers Squibb
Celgene
Clinuvel Pharmaceuticals